144. レノックス・ガストー症候群 Lennox-Gastaut syndrome Clinical trials / Disease details

臨床試験数 : 111 / 薬物数 : 72 - (DrugBank : 14) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 61

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04485104 (ClinicalTrials.gov)	May 19, 2021	21/7/2020	Assessment of Adjunctive Cannabidiol Oral Solution(GWP42003-P) in Children With Tuberous Sclerosis C ...	An Open-label, Single-arm Study to Assess the Safety, Pharmacokinetics, and Efficacy of Adjunctive C ...	Seizure in Participants With Tuberous Sclerosis Complex;Seizure in Participants With Dravet Syndrome ...	Drug: GWP42003-P	Jazz Pharmaceuticals	NULL	Recruiting	1 Month	23 Months	All	27	Phase 3	United States
2	NCT04133480 (ClinicalTrials.gov)	October 2020	17/10/2019	Investigation of Cognitive Outcomes With Cannabidiol Oral Solution	An Open-Label Exploratory Investigation of Cognitive Outcomes With Cannabidiol Oral Solution(EPIDIOL ...	Lennox-Gastaut Syndrome	Drug: GWP42003-P	Jazz Pharmaceuticals	NULL	Withdrawn	3 Years	10 Years	All	0	Phase 4	United States
3	NCT02318537 (ClinicalTrials.gov)	December 30, 2017	12/12/2014	Cannabidiol Oral Solutionas an Adjunctive Therapy for Treatment of Participants With Inadequately Co ...	A Multicenter, Randomized, Double-blind, Placebo-controlled, Interventional Study to Assess the Safe ...	Lennox-Gastaut Syndrome	Drug: Cannabidiol Oral Solution;Drug: Placebo Solution	INSYS Therapeutics Inc	NULL	Withdrawn	2 Years	30 Years	All	0	Phase 3	NULL

First Previous1Next Last